Shamis & gentile, p.a. notifies investors it has filed a complaint to recover losses suffered by purchasers of sarepta therapeutics, inc. securities and sets a lead plaintiff deadline of august 25, 2025

Miami, june 26, 2025 (globe newswire) -- the following statement is being issued by shamis & gentile, p.a: to: all persons or entities who purchased or otherwise acquired sarepta therapeutics, inc. (“sarepta” or the “company”) (nasdaq:srpt) securities between june 22, 2023, and june 24, 2025, inclusive. you are hereby notified that the class action lawsuit dolgicer, jr. v.
SRPT Ratings Summary
SRPT Quant Ranking